Revive Therapeutics, University of Wisconsin-Madison ink deal for cannabinoid drug delivery tech

Revive Therapeutics (OTC:RVVTF) said today that it inked a research agreement with the University of Wisconsin-Madison to develop a drug delivery technology for cannibinoids.

The research program, led by Jess Reed, is slated to evaluate chitosan-tannin composite biomaterial as a delivery mechanism for cannabinoids. Therapeutic biomaterials made from a composite of chitosan and tannin include nanoparticles, hydrogels, bio-foams, bio-gels or a liposomal coating.

Get the full story at our sister site, Drug Delivery Business News.

The post Revive Therapeutics, University of Wisconsin-Madison ink deal for cannabinoid drug delivery tech appeared first on MassDevice.

from MassDevice http://ift.tt/2s9R6Du